ANR Insider Trading

Insider Ownership Percentage: 31.18%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Anatara Lifesciences Insider Trading History Chart

This chart shows the insider buying and selling history at Anatara Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Anatara Lifesciences Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ANR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Anatara Lifesciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2022David BrookesInsiderIssued857,143A$0.04A$32,571.43
12/16/2022Jane RyanInsiderIssued142,858A$0.04A$5,000.03
12/12/2022David BrookesInsiderCancelled65,658A$0.04A$2,298.03
12/3/2020Sue MacLemanInsiderIssued122,548A$0.18A$21,445.90
11/18/2020Sue MacLemanInsiderBuy33,333A$0.15A$4,999.95
See Full Table

SEC Filings (Institutional Ownership Changes) for Anatara Lifesciences (ASX:ANR)

8.23% of Anatara Lifesciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.
Read More on Anatara Lifesciences

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


3,950 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Anatara Lifesciences?

Anatara Lifesciences' top insider shareholders include:
  1. David Brookes (Insider)
  2. Jane Ryan (Insider)
Learn More about top insider investors at Anatara Lifesciences.